Compare WMK & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMK | BHC |
|---|---|---|
| Founded | 1912 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 1994 | 1996 |
| Metric | WMK | BHC |
|---|---|---|
| Price | $71.15 | $6.59 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 145.2K | ★ 5.2M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 2.05 | N/A |
| Revenue | $4,714,573,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.58 | ★ N/A |
| Revenue Growth | ★ 0.01 | N/A |
| 52 Week Low | $59.99 | $4.33 |
| 52 Week High | $83.74 | $8.00 |
| Indicator | WMK | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 61.36 |
| Support Level | $70.48 | $5.48 |
| Resistance Level | $72.58 | $7.32 |
| Average True Range (ATR) | 1.63 | 0.31 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 44.76 | 68.07 |
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.